A200230 Share Price Performance
₩5,340.00
-1480.00 (-21.70%)
Price ₩5,340.00
Share Price₩5,340.00
A200230 Community Narratives
There are no narratives available yet.
Recent A200230 News & Updates
No updates
TELCON RF PHARMACEUTICAL. Inc. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -2.80k
- Gross Margin
- 25.72%
- Net Profit Margin
- -84.57%
- Debt/Equity Ratio
- 81.7%
TELCON RF PHARMACEUTICAL. Inc. Competitors
About A200230
- Founded
- 1999
- Employees
- 124
- CEO
- WebsiteView website
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
South Korean Market Performance
- 7 Days: -2.0%
- 3 Months: 20.9%
- 1 Year: 26.1%
- Year to Date: 28.6%
Over the last 7 days, the market has dropped 2.0%, driven by losses in the Materials and Information Technology sectors of 7.0% and 1.3%, respectively. As for the longer term, the market has actually risen by 26% in the last year. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading